Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Bruce D. Cheson, MD, Beate Pfistner, PhD, Malik E. Juweid, MD, Lena Specht, MD, PhD, Steven T. Rosen, MD, Randy Gascoyne, MD, Sigrid Stroobants, MD, PhD, Volker Diehl, MD

Blood (2005) 106 (11): 18.

https://doi.org/10.1182/blood.V106.11.18.18

Published: 2005

Journal Articles

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Andreas Josting, MD, Jeremy Franklin, PhD, Michal Sieniawski, MD, Beate Pfistner, PhD, Thomas Schober, Hildtrud Nisters-Backes, Andreas Engert, MD, Volker Diehl, MD

Blood (2005) 106 (11): 818.

https://doi.org/10.1182/blood.V106.11.818.818

Published: 2005

Journal Articles

Hodgin’s Lymphoma in Elderly Patients: A Comprehensive Analysis of the German Hodgkin Lymphoma Study Group (GHSG).

Andreas Engert, MD, Veronika Ballova, MD, Heinz Haverkamp, Beate Pfistner, PhD, Volker Diehl, MD

Blood (2004) 104 (11): 1306.

https://doi.org/10.1182/blood.V104.11.1306.1306

Published: 2004

Journal Articles

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

Lucia Nogova, MD, Thorsten Reineke, Andreas Josting, MD, Karolin Behringer, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 1309.

https://doi.org/10.1182/blood.V104.11.1309.1309

Published: 2004

Journal Articles

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Beate Klimm, MD, Thorsten Reineke, Heinz Haverkamp, Hans T. Eich, MD, Andreas Josting, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 1313.

https://doi.org/10.1182/blood.V104.11.1313.1313

Published: 2004

NARROW

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Hodgin’s Lymphoma in Elderly Patients: A Comprehensive Analysis of the German Hodgkin Lymphoma Study Group (GHSG).

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Email alerts

ASH Publications

American Society of Hematology

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Hodgin’s Lymphoma in Elderly Patients: A Comprehensive Analysis of the German Hodgkin Lymphoma Study Group (GHSG).

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only